BrainsWay (NASDAQ:BWAY – Get Free Report) and United American Healthcare (OTCMKTS:UAHC – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.
Valuation & Earnings
This table compares BrainsWay and United American Healthcare”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BrainsWay | $38.63 million | 5.21 | -$4.20 million | $0.10 | 106.90 |
| United American Healthcare | N/A | N/A | $720,000.00 | N/A | N/A |
United American Healthcare has lower revenue, but higher earnings than BrainsWay.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BrainsWay | 0 | 0 | 3 | 0 | 3.00 |
| United American Healthcare | 0 | 0 | 0 | 0 | 0.00 |
BrainsWay presently has a consensus price target of $13.17, indicating a potential upside of 23.17%. Given BrainsWay’s stronger consensus rating and higher probable upside, equities research analysts clearly believe BrainsWay is more favorable than United American Healthcare.
Institutional & Insider Ownership
30.1% of BrainsWay shares are owned by institutional investors. 19.0% of BrainsWay shares are owned by company insiders. Comparatively, 14.3% of United American Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
BrainsWay has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.29, indicating that its stock price is 229% less volatile than the S&P 500.
Profitability
This table compares BrainsWay and United American Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BrainsWay | 3.88% | 3.52% | 2.26% |
| United American Healthcare | N/A | N/A | N/A |
Summary
BrainsWay beats United American Healthcare on 10 of the 11 factors compared between the two stocks.
About BrainsWay
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
About United American Healthcare
United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.
Receive News & Ratings for BrainsWay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrainsWay and related companies with MarketBeat.com's FREE daily email newsletter.
